Volver a Agenda
Session Chair(s)
Nancy A Dreyer, PHD, MPH, FISPE
Founder
Dreyer Strategies LLC, United States
Learning Objective : Describe differences in legislation for risk management between the US, EU, and Asia; Recognize challenges of different legislation, health care systems, and medical practice; Implement effective global risk management planning.
Speaker(s)
FDA Perspective
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
EU Perspective
Peter Richard Arlett, MD, FFPM, FRCP
European Medicines Agency, Netherlands
Head Data Analytics and Methods Task Force
Japan Risk Management Plans (RMP): Experience in Its First Year
E. Stewart Geary, MD
Eisai Co., Ltd., Japan
MD, Global Safety Officer
¿Tiene una cuenta?